Inflation Reduction Act

After IRA, Minnesota's drug affordability proposal draws PhRMA's ire
After IRA, Minnesota's drug affordability proposal draws PhRMA's ire
Fierce Pharma
Inflation Reduction Act
PhRMA
drug pricing
Minnesota
Flag link:
Pharma, patient advocates clash over Inflation Reduction Act
Pharma, patient advocates clash over Inflation Reduction Act
Clinical Trials Arena
Inflation Reduction Act
drug pricing
patient advocacy groups
innovation
Flag link:
Pfizer CEO Bourla slams Medicare IRA measure as 'negotiation with a gun to your head'
Pfizer CEO Bourla slams Medicare IRA measure as 'negotiation with a gun to your head'
Fierce Pharma
Pfizer
Albert Bourla
drug pricing
Pharma CEOs
Inflation Reduction Act
Flag link:
Pharma is clearly not done fighting drug-pricing reforms
Pharma is clearly not done fighting drug-pricing reforms
Medical Marketing and Media
drug pricing
Inflation Reduction Act
PhRMA
Flag link:
Pharma Decries Drug Selection Plans in Medicare Pricing Policy
Pharma Decries Drug Selection Plans in Medicare Pricing Policy
RAPS.org
Medicare
drug pricing
CMS
Inflation Reduction Act
Flag link:
The Inflation Reduction Act: 10 Predictions About Market Access and Drug Channels
The Inflation Reduction Act: 10 Predictions About Market Access and Drug Channels
Drug Channels
Inflation Reduction Act
drug pricing
340B
Medicare Part D
Flag link:
How the IRA Will Affect Drug Development
How the IRA Will Affect Drug Development
BioSpace
Inflation Reduction Act
drug development
Flag link:
Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026
Pfizer, BMS' Eliquis tops list of drugs destined for Medicare price negotiations in 2026
Fierce Pharma
Pfizer
Bristol Myers Squibb
Eliquis
drug pricing
Inflation Reduction Act
CMS
Flag link:
Pfizer CEO points to IRA as a factor that made Seagen an attractive target
Pfizer CEO points to IRA as a factor that made Seagen an attractive target
Endpoints
Pfizer
Seagen
M&A
Inflation Reduction Act
Flag link:
Medicare announces plan to recoup billions from drug companies
Medicare announces plan to recoup billions from drug companies
NPR
Medicare
drug pricing
Inflation Reduction Act
Flag link:
Inside pharma’s push to amend new drug-pricing law
Inside pharma’s push to amend new drug-pricing law
Medical Marketing and Media
drug pricing
Inflation Reduction Act
Flag link:
Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback
Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback
Fierce Pharma
Novartis
Vas Narasimhan
PhRMA
Inflation Reduction Act
PBMs
small molecule drugs
Flag link:
Legislative Hurdles Anticipated for Biopharma in 2023
Legislative Hurdles Anticipated for Biopharma in 2023
BioSpace
legislation
M&A
FDA
Inflation Reduction Act
Flag link:
JPM2023: Breakthroughs await, but so do roadblocks
JPM2023: Breakthroughs await, but so do roadblocks
Pharmaphorum
JPMHC 2023
Inflation Reduction Act
cell therapy
gene therapy
clinical trials
CNS disorders
Flag link:
5 questions facing emerging biotech in 2023
5 questions facing emerging biotech in 2023
BioPharma Dive
biotech
IPOs
platform companies
funding
restructuring
Inflation Reduction Act
Flag link:
Aligning drug prices with ICER estimates could save tens of billions of dollars — JAMA paper
Aligning drug prices with ICER estimates could save tens of billions of dollars — JAMA paper
Endpoints
ICER
Inflation Reduction Act
drug pricing
Flag link:
Bristol Myers Squibb Threatens New Rules Will Hinder Drug Production
Bristol Myers Squibb Threatens New Rules Will Hinder Drug Production
Motley Fool
Bristol Myers Squibb
drug development
Inflation Reduction Act
Flag link:
Sanofi, Alnylam Q3 Reports Hint at Early Pipeline Impacts from IRA
Sanofi, Alnylam Q3 Reports Hint at Early Pipeline Impacts from IRA
BioSpace
Sanofi
Alnylam
earnings
Inflation Reduction Act
legislation
drug pricing
Flag link:
Alnylam scraps trial in rare eye disorder, blaming drug price reforms
Alnylam scraps trial in rare eye disorder, blaming drug price reforms
Pharmaphorum
Alnylam
RNAi
vutrisiran
Stargardt disease
Inflation Reduction Act
drug pricing
Flag link:
US govt addressing Medicare payments for biosimilars
US govt addressing Medicare payments for biosimilars
Pharma Letter
HHS
Medicare
biosimilars
Medicare Part B
Inflation Reduction Act
CMS
Flag link:

Pages